Key takeaways
- FDA says that in most circumstances it is illegal for individuals to import unapproved drugs; its personal importation policy is discretion, not a right.
- A detained US parcel comes with a Notice of FDA Action; the response window is generally 20 calendar days, and refused drugs valued at $2,500 or less can be destroyed.
- In the UK, importing a medicinal product generally needs a licence; Border Force seizes unlicensed medicines at the border, and a notice of claim must arrive within one month.
- Australia’s Personal Importation Scheme requires an Australian prescription for prescription-only medicines, and the TGA says peptides labelled only with codes will not be considered for release.
- An Australian claim for seized goods must be made within 30 days of the seizure notice, and making one does not guarantee the goods come back.
01The rules at a glance
Each country asks two questions: may this be imported at all, and what happens to a parcel that is stopped?
| Country | What the law says about importing | Who holds the parcel | Window to respond |
|---|---|---|---|
| United States | Illegal in most circumstances for individuals to import unapproved drugs; FDA may use discretion for personal imports | FDA, at mail and courier facilities | The “respond by” date on FDA’s notice, generally 20 calendar days |
| United Kingdom | A licence is generally needed to import a medicinal product (Human Medicines Regulations 2012, regulation 17) | Border Force or HMRC | Notice of claim within one month; restoration request, no deadline |
| Australia | The TGA’s Personal Importation Scheme sets conditions, including an Australian prescription for prescription-only medicines | Australian Border Force; the TGA decides on release of therapeutic goods | Claim within 30 days of the seizure notice |
Whether a given peptide is lawful at all is covered country by country: US, UK and Australia.
02United States: FDA detention and refusal
FDA’s position: “In most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use”, including drugs approved abroad but not in the US.
The personal importation policy. FDA says its personnel “may consider a more permissive decision” only in limited situations, and it lists the reasons it refuses a personal import, including that a product “is on an FDA import alert”.
Import alerts. An import alert lets FDA detain products from listed firms without examining them. The Red List of Import Alert 66-41, in the version published on 12 November 2026, includes peptide products from foreign firms, such as melanotan. One entry notes the product “is imported as non-human research purposes only and then the unapproved new drug is sold on internet”. Release requires evidence “that the shipment does not contain unapproved new drug products.”
If a parcel is detained:
FDA issues a Notice of FDA Action marked “Detained”, also called a Notice of Detention and Hearing. It lists the charges, a contact, usually a compliance officer, and a “respond by” date.
FDA says the importer has “the right to provide oral or written testimony”: any information that could overcome the appearance of a violation. FDA’s procedures allow 10 business days; the notice generally gives 20 calendar days. An extension can be requested within that time, with a reasonable basis.
FDA issues a second notice: the product is released, or refused with written reasons. With no response, the compliance officer can refuse admission.
Refused drugs valued at $2,500 or less can be destroyed without an option to export, under authority Congress gave FDA in 2012, which FDA began using for drugs on 4 April 2016. The notice says whether the product will be destroyed or returned to sender.
03United Kingdom: Border Force and the MHRA
UK medicines law generally requires a licence to import a medicinal product into Great Britain.
Regulation 17(1) of the Human Medicines Regulations 2012 requires a manufacturer’s licence to import a medicinal product into Great Britain from outside Northern Ireland or an approved country.
In a March 2022 freedom-of-information reply, the MHRA reported that Border Force seizures notified to it totalled 6,320,344 doses of unlicensed medicines, excluding controlled drugs, from March 2021 to February 2022.
Selling or supplying is a separate question, and growth hormone and HCG are controlled drugs with their own rules. Both are covered on are peptides legal in the UK.
If Border Force seizes a parcel:
The notice or letter from customs carries a seizure reference number. Unless the owner acts, customs “will destroy or sell anything it seizes”.
A restoration request is possible even if the owner accepts the seizure was lawful. There is no deadline, but non-perishable goods are usually destroyed or sold 45 days after seizure; a pending request usually keeps them. A fee may apply.
An owner who thinks the seizure was illegal can send a notice of claim. It must be received within a month of the seizure, by Border Force’s National post seizure unit in Plymouth if Border Force seized the goods. The case goes to court, and a claimant who loses may have to pay costs. Anyone living outside the UK must appoint a UK solicitor.
A refused restoration request can be reviewed, and the review appealed to the tax tribunal.
04Australia: the Personal Importation Scheme and ABF seizures
In Australia, the TGA’s Personal Importation Scheme sets the conditions for personal imports of unapproved therapeutic goods.
The TGA’s scheme page, last updated 8 September 2026, says a medicine that is prescription-only in Australia needs a valid Australian prescription or written authority held at the time of importation, and that one obtained after the import has been held does not comply. It says counterfeit medicines are prohibited under any circumstances, and that products must be in packaging that allows them to be accurately identified: if the labels are not intact, the importer will not receive the products.
On peptides, the TGA said in April 2026 that products “identified only by codes”, or not clearly stating the active ingredient or strength, “will not be considered for release”, and that “research use only” disclaimers do not, on their own, “permit importation”. Which peptides are scheduled by name as prescription-only, and the possession rules, are on are peptides legal in Australia.
If the ABF seizes goods under the Customs Act:
It must be served within 7 days and state the goods, the day they were seized, the grounds, and the effect of the claim rules (Customs Act 1901, sections 205 and 205A).
The owner may claim the goods back, on the approved form or electronically, stating the grounds. If no claim is made 30 days after the notice was served, the goods “are taken to be condemned as forfeited to the Crown” (sections 205B and 205C).
The goods must be returned unless, for example, proceedings begun within 120 days end in a court condemning them as forfeited, or another law permits keeping or destroying them (section 205D). A claim is not a guarantee.
The TGA adds that people who cannot show an import complies may face “significant fines, or civil or criminal proceedings.”
05What we don’t know
How often peptide parcels are stopped. We found no published counts specific to peptides in any of the three countries.
How a given product would be treated. FDA’s personal importation decisions are discretionary and not published case by case.
Changes are logged in our regulatory changelog. To report a suspect product rather than a parcel, see how to report a reaction or a suspect product.
This is a plain-English summary of public documents, checked on 18 Nov 2026. It is not legal advice.